These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38713384)

  • 1. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.
    González-Martínez S; Kajabova VH; Pérez-Mies B; Carretero-Barrio I; Caniego-Casas T; Sarrió D; Moreno-Bueno G; Gión M; Perez-García J; Cortés J; Smolkova B; Palacios J
    Virchows Arch; 2024 Aug; 485(2):291-297. PubMed ID: 38713384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
    Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
    J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma.
    Djerroudi L; Bendali A; Fuhrmann L; Benoist C; Pierron G; Masliah-Planchon J; Kieffer Y; Carton M; Tille JC; Cyrta J; Ramtohul T; Bonneau C; Caly M; Renault V; Bidard FC; Mechta-Grigoriou F; Vincent-Salomon A
    Mod Pathol; 2024 Oct; 37(10):100570. PubMed ID: 39025406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
    Grabenstetter A; Mohanty AS; Rana S; Zehir A; Brannon AR; D'Alfonso TM; DeLair DF; Tan LK; Ross DS
    Hum Pathol; 2020 Aug; 102():44-53. PubMed ID: 32599083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into E-Cadherin Impairment in
    Uchida S; Sugino T
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
    Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
    Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
    Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
    Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
    Ross JS; Wang K; Sheehan CE; Boguniewicz AB; Otto G; Downing SR; Sun J; He J; Curran JA; Ali S; Yelensky R; Lipson D; Palmer G; Miller VA; Stephens PJ
    Clin Cancer Res; 2013 May; 19(10):2668-76. PubMed ID: 23575477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
    Droufakou S; Deshmane V; Roylance R; Hanby A; Tomlinson I; Hart IR
    Int J Cancer; 2001 May; 92(3):404-8. PubMed ID: 11291078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
    Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
    Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed ductal-lobular carcinoma: an analysis of CDH1 DNA copy number variation and mutation.
    Tang X; Nakanishi Y; Kobayashi H; Nishimaki H; Kusumi Y; Miyagi Y; Masuda S
    Breast Cancer; 2021 Nov; 28(6):1318-1327. PubMed ID: 34185256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium.
    De Schepper M; Koorman T; Richard F; Christgen M; Vincent-Salomon A; Schnitt SJ; van Diest PJ; Zels G; Mertens F; Maetens M; Vanden Bempt I; Harbeck N; Nitz U; Gräser M; Kümmel S; Gluz O; Weynand B; Floris G; Derksen PWB; Desmedt C;
    Mod Pathol; 2024 Jul; 37(7):100497. PubMed ID: 38641322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
    Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
    Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.
    Elangovan A; Hooda J; Savariau L; Puthanmadhomnarayanan S; Yates ME; Chen J; Brown DD; McAuliffe PF; Oesterreich S; Atkinson JM; Lee AV
    Mol Cancer Res; 2022 Sep; 20(9):1405-1419. PubMed ID: 35665642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of E-cadherin in low-grade ductal breast tumourigenesis.
    Roylance R; Droufakou S; Gorman P; Gillett C; Hart IR; Hanby A; Tomlinson I
    J Pathol; 2003 May; 200(1):53-8. PubMed ID: 12692841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.